ETFs: Drug Pricing Policy Shapes PPH Risks in 2026
The VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Wealth planning tools are essential for financial success. Discover resources that can help you achieve your financial aspirations.
28,655 articlesThe VanEck PPH ETF faces two key risks in 2026: heavy concentration in Eli Lilly and shifting U.S. drug pricing polic...
Bitcoin price just lost momentum after a hotter-than-expected US PPI. Traders weigh how sticky inflation could delay ...
AMD sits near a pivotal $420 level as first-quarter results underscore strong data-center demand and a bold AI-driven...
A memory-focused rally has vaulted a mid-cap equipment maker by about 90% in 2.5 months, shifting attention away from...
Applied Optoelectronics has rocketed higher in 2026, delivering a 439% year-to-date gain as hyperscale AI data center...
Eli Lilly stock is surging on fresh obesity-drug data, fueling bets that the name could push toward a record high wit...
Netflix’s ad-supported tier is gaining traction and subscribers are rising, even as the broader market spurs a debate...
As the quarter winds down, Monday’s best Wall Street calls set the tone, spotlighting tech, energy and consumer names...
A rural Maine factory once central to pandemic testing is expanding its operations and product lines, highlighting a ...
Shares have pulled back from recent highs, but Nvidia’s momentum in AI data centers remains strong. Analysts see a fr...
German carmakers posted steep Q2 declines in China, with losses up to 41%. The drop highlights ongoing headwinds from...
Fidelis Investors closed its fourth rated residential transition loan securitization, a $191.5 million deal backed by...